Clinical Trial Operations
Regulatory and Drug Development Consulting
Government and Public Health Services
Biometrics
Clinical Pharmacology Modeling SimulationAcquired Thrombotic Thrombocytopenic Purpura (aTTP)
Case Study
About the Case Study
Acquired Thrombotic Thrombocytopenic Purpura (aTTP) is a rare disease that, when left untreated leads to a 95% morbidity rate. However, 80-90% of patients that receive treatment respond favorably. In this Phase III study, Allucent is partnering with a progressive sponsor company to assist in finding a better solution for suffering with aTTP.
Sites & Locations:
91+ Sites across 25 countries in Asia, Eastern and Western Europe and North America
Services Provided:
- Site Identification & Selection
- Regulatory
- Clinical & Medical Monitoring
- Project Management
- Medical Writing